Wegovy (semaglutide) for weight loss, honestly explained
Wegovy is the weight-loss brand of semaglutide, a once-weekly GLP-1 shot a doctor prescribes. In the STEP 1 trial it gave about 15% mean weight loss over 68 weeks, used WITH a reduced-calorie diet and more activity. It is the same active drug as Ozempic, just a different brand and approved use. Your doctor decides if it fits you, and you should never self-source it online.
You have heard the buzz about Wegovy, the once-weekly shot for weight loss. Maybe a friend mentioned it, or you saw it in the news when it launched in India. Now you want the honest picture: what it is, what it does, what it costs, and what it does not do. This article gives you that, in plain words. The big idea first: Wegovy is a brand of a medicine called semaglutide. It is not a magic injection. It works best when you also eat a little less and move a little more. And your doctor, not you and not a website, decides if it is right for you and what dose to use.
What Wegovy is and what it is approved for
Wegovy is a brand name for semaglutide, a GLP-1 receptor agonist. That means it copies a gut hormone that tells your brain you are full, so you eat less. The US FDA approved it for chronic weight management in adults with obesity, or in adults who are overweight with at least one weight-related condition like high blood pressure or type-2 diabetes. The FDA also approved it to lower the risk of serious heart problems in adults who already have heart disease and are overweight or have obesity. In the big STEP 1 trial, people on the weekly weight-loss dose lost about 15% of their body weight over 68 weeks, compared with about 2.4% on a dummy injection, but only when they also cut calories and moved more. Here is the key thing people miss: Wegovy is the SAME active drug as Ozempic. Both are semaglutide. The difference is the brand, the dose, and what it was approved for. Your doctor decides which fits your case.
Wegovy is a different, better drug than Ozempic.
falseFalse. Wegovy and Ozempic are the SAME active drug, semaglutide, a GLP-1 receptor agonist. They are two brand names from the same company, with different doses and different FDA-approved uses. Wegovy is approved mainly for chronic weight management and for lowering heart-risk in adults with established heart disease and overweight or obesity. Ozempic is approved mainly for type-2 diabetes blood sugar control. There is real overlap in the science, and a doctor may use either in some situations, but 'Wegovy is a better drug' is the wrong way to think about it. The right question is: which medicine, at which dose, fits YOUR health and YOUR goals? That is a doctor's call, not an Instagram reel's.
If your doctor suggests Wegovy, what to know and do
- Let your doctor decide. An endocrinologist or obesity-medicine doctor checks your weight, health, and history first. Wegovy is not for everyone, and it is not for casual weight loss.
- Use it WITH diet and activity. The medicine helps you feel full and eat less, but the label says it must be used with a reduced-calorie diet and more physical activity. The food log and the daily walk still do the heavy lifting.
- Expect a slow start. Your doctor starts low and steps the dose up over several weeks to a weekly maintenance dose. This lowers stomach side effects. Never jump to a high dose or share a pen with anyone.
- Know the common side effects. Nausea, vomiting, diarrhea, and constipation are common, usually in the first weeks. Tell your doctor if they are severe or do not settle.
- Know the red flags. Bad stomach pain that reaches the back can mean pancreatitis, stop and get help. Sudden kidney trouble, severe dehydration from vomiting, or a lump in the neck need urgent care. Call your doctor.
- Do not self-source online. WHO has warned about falsified semaglutide pens in the market, some even filled with insulin instead of the real medicine. Buy only from a licensed pharmacy with a genuine prescription.
- Not for pregnancy. Tell your doctor if you are pregnant, planning, or breastfeeding. The label says to stop when pregnancy is recognised, because weight loss gives no benefit in pregnancy and may harm the baby.
- In India, Novo Nordisk launched Wegovy in 2025. It is an imported once-weekly pen, available through proper pharmacies with a prescription, not through online deals. It costs several thousand rupees a month — a significant ongoing cost, so talk to your doctor about whether it is right for you.
The bottom line
Wegovy is the weight-loss brand of semaglutide, a once-weekly GLP-1 shot. In the STEP 1 trial it gave about 15% mean weight loss over 68 weeks, but only with a reduced-calorie diet and more activity, and only when a doctor prescribed the right dose and stepped it up slowly. It is the same active drug as Ozempic, just a different brand, dose, and approved use. It has real side effects and rare serious risks, and it is not for pregnancy. In India it is now available through proper pharmacies with a prescription, at a significant monthly cost. The honest take: Wegovy is a useful tool, not a shortcut. Talk to your doctor, keep logging your food in Burnie, keep walking, and let the medicine help the deficit you are already building.